Guidelines for Heart Failure with Preserved Ejection Fraction

Half of patients with heart failure have Heart Failure with Preserved Ejection Fraction (HFpEF).  Join host, Geoff Wall, as he talks about the new guidelines from the American College of Cardiology for diagnosis, treatment, and challenges in therapy for persons with HFpEF.The GameChangerHFpEF is the fastest growing cause of heart failure and is often difficult to diagnose. New therapies are shown to improve symptoms and decrease hospitalizations. Management of comorbid conditions, like obesity and diabetes, is critical to optimizing care. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferenceKittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19. PMID: 37137593. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the H2FPEF scoring system for HFpEF diagnosis2. Apply the new practice guidelines to HFpEF patient pharmacotherapy 0.05 CEU/0.5 HrUAN: 0107-0000-23-228-H01-PInitial release date: 6/19/2023Expiration date: 6/19/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram